Global Metabotropic Glutamate Receptor 4 Market Insights and Forecast to 2026
Table of Contents1 Study Coverage
1.1 Metabotropic Glutamate Receptor 4 Product Introduction
1.2 Market Segments
1.3 Key Metabotropic Glutamate Receptor 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Metabotropic Glutamate Receptor 4 Market Size Growth Rate by Type
1.4.2 VU-0418506
1.4.3 ADX-88178
1.4.4 JBPOS-0101
1.4.5 PXT-2331
1.4.6 Others
1.5 Market by Application
1.5.1 Global Metabotropic Glutamate Receptor 4 Market Size Growth Rate by Application
1.5.2 Anxiety Disorders
1.5.3 Autism
1.5.4 Depression
1.5.5 Drug Addiction
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Metabotropic Glutamate Receptor 4 Market Size, Estimates and Forecasts
2.1.1 Global Metabotropic Glutamate Receptor 4 Revenue 2015-2026
2.1.2 Global Metabotropic Glutamate Receptor 4 Sales 2015-2026
2.2 Global Metabotropic Glutamate Receptor 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Metabotropic Glutamate Receptor 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Metabotropic Glutamate Receptor 4 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Metabotropic Glutamate Receptor 4 Competitor Landscape by Players
3.1 Metabotropic Glutamate Receptor 4 Sales by Manufacturers
3.1.1 Metabotropic Glutamate Receptor 4 Sales by Manufacturers (2015-2020)
3.1.2 Metabotropic Glutamate Receptor 4 Sales Market Share by Manufacturers (2015-2020)
3.2 Metabotropic Glutamate Receptor 4 Revenue by Manufacturers
3.2.1 Metabotropic Glutamate Receptor 4 Revenue by Manufacturers (2015-2020)
3.2.2 Metabotropic Glutamate Receptor 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Metabotropic Glutamate Receptor 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 4 Revenue in 2019
3.2.5 Global Metabotropic Glutamate Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Metabotropic Glutamate Receptor 4 Price by Manufacturers
3.4 Metabotropic Glutamate Receptor 4 Manufacturing Base Distribution, Product Types
3.4.1 Metabotropic Glutamate Receptor 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Metabotropic Glutamate Receptor 4 Product Type
3.4.3 Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Metabotropic Glutamate Receptor 4 Market Size by Type (2015-2020)
4.1.1 Global Metabotropic Glutamate Receptor 4 Sales by Type (2015-2020)
4.1.2 Global Metabotropic Glutamate Receptor 4 Revenue by Type (2015-2020)
4.1.3 Metabotropic Glutamate Receptor 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Metabotropic Glutamate Receptor 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global Metabotropic Glutamate Receptor 4 Sales Forecast by Type (2021-2026)
4.2.2 Global Metabotropic Glutamate Receptor 4 Revenue Forecast by Type (2021-2026)
4.2.3 Metabotropic Glutamate Receptor 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Metabotropic Glutamate Receptor 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Metabotropic Glutamate Receptor 4 Market Size by Application (2015-2020)
5.1.1 Global Metabotropic Glutamate Receptor 4 Sales by Application (2015-2020)
5.1.2 Global Metabotropic Glutamate Receptor 4 Revenue by Application (2015-2020)
5.1.3 Metabotropic Glutamate Receptor 4 Price by Application (2015-2020)
5.2 Metabotropic Glutamate Receptor 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global Metabotropic Glutamate Receptor 4 Sales Forecast by Application (2021-2026)
5.2.2 Global Metabotropic Glutamate Receptor 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global Metabotropic Glutamate Receptor 4 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Metabotropic Glutamate Receptor 4 by Country
6.1.1 North America Metabotropic Glutamate Receptor 4 Sales by Country
6.1.2 North America Metabotropic Glutamate Receptor 4 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Metabotropic Glutamate Receptor 4 Market Facts & Figures by Type
6.3 North America Metabotropic Glutamate Receptor 4 Market Facts & Figures by Application
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 4 by Country
7.1.1 Europe Metabotropic Glutamate Receptor 4 Sales by Country
7.1.2 Europe Metabotropic Glutamate Receptor 4 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Metabotropic Glutamate Receptor 4 Market Facts & Figures by Type
7.3 Europe Metabotropic Glutamate Receptor 4 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Metabotropic Glutamate Receptor 4 by Region
8.1.1 Asia Pacific Metabotropic Glutamate Receptor 4 Sales by Region
8.1.2 Asia Pacific Metabotropic Glutamate Receptor 4 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Metabotropic Glutamate Receptor 4 Market Facts & Figures by Type
8.3 Asia Pacific Metabotropic Glutamate Receptor 4 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Metabotropic Glutamate Receptor 4 by Country
9.1.1 Latin America Metabotropic Glutamate Receptor 4 Sales by Country
9.1.2 Latin America Metabotropic Glutamate Receptor 4 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Metabotropic Glutamate Receptor 4 Market Facts & Figures by Type
9.3 Central & South America Metabotropic Glutamate Receptor 4 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Metabotropic Glutamate Receptor 4 by Country
10.1.1 Middle East and Africa Metabotropic Glutamate Receptor 4 Sales by Country
10.1.2 Middle East and Africa Metabotropic Glutamate Receptor 4 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Metabotropic Glutamate Receptor 4 Market Facts & Figures by Type
10.3 Middle East and Africa Metabotropic Glutamate Receptor 4 Market Facts & Figures by Application
11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 4 Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments
11.2 Domain Therapeutics SA
11.2.1 Domain Therapeutics SA Corporation Information
11.2.2 Domain Therapeutics SA Description and Business Overview
11.2.3 Domain Therapeutics SA Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 4 Products Offered
11.2.5 Domain Therapeutics SA Related Developments
11.3 Prexton Therapeutics SA
11.3.1 Prexton Therapeutics SA Corporation Information
11.3.2 Prexton Therapeutics SA Description and Business Overview
11.3.3 Prexton Therapeutics SA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Prexton Therapeutics SA Metabotropic Glutamate Receptor 4 Products Offered
11.3.5 Prexton Therapeutics SA Related Developments
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 4 Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Metabotropic Glutamate Receptor 4 Market Estimates and Projections by Region
12.1.1 Global Metabotropic Glutamate Receptor 4 Sales Forecast by Regions 2021-2026
12.1.2 Global Metabotropic Glutamate Receptor 4 Revenue Forecast by Regions 2021-2026
12.2 North America Metabotropic Glutamate Receptor 4 Market Size Forecast (2021-2026)
12.2.1 North America: Metabotropic Glutamate Receptor 4 Sales Forecast (2021-2026)
12.2.2 North America: Metabotropic Glutamate Receptor 4 Revenue Forecast (2021-2026)
12.2.3 North America: Metabotropic Glutamate Receptor 4 Market Size Forecast by Country (2021-2026)
12.3 Europe Metabotropic Glutamate Receptor 4 Market Size Forecast (2021-2026)
12.3.1 Europe: Metabotropic Glutamate Receptor 4 Sales Forecast (2021-2026)
12.3.2 Europe: Metabotropic Glutamate Receptor 4 Revenue Forecast (2021-2026)
12.3.3 Europe: Metabotropic Glutamate Receptor 4 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Metabotropic Glutamate Receptor 4 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Metabotropic Glutamate Receptor 4 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Metabotropic Glutamate Receptor 4 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Metabotropic Glutamate Receptor 4 Market Size Forecast by Region (2021-2026)
12.5 Latin America Metabotropic Glutamate Receptor 4 Market Size Forecast (2021-2026)
12.5.1 Latin America: Metabotropic Glutamate Receptor 4 Sales Forecast (2021-2026)
12.5.2 Latin America: Metabotropic Glutamate Receptor 4 Revenue Forecast (2021-2026)
12.5.3 Latin America: Metabotropic Glutamate Receptor 4 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Metabotropic Glutamate Receptor 4 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Metabotropic Glutamate Receptor 4 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Metabotropic Glutamate Receptor 4 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Metabotropic Glutamate Receptor 4 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Metabotropic Glutamate Receptor 4 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Metabotropic Glutamate Receptor 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Metabotropic Glutamate Receptor 4 Market Segments
Table 2. Ranking of Global Top Metabotropic Glutamate Receptor 4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Metabotropic Glutamate Receptor 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of VU-0418506
Table 5. Major Manufacturers of ADX-88178
Table 6. Major Manufacturers of JBPOS-0101
Table 7. Major Manufacturers of PXT-2331
Table 8. Major Manufacturers of Others
Table 9. Global Metabotropic Glutamate Receptor 4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Metabotropic Glutamate Receptor 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Metabotropic Glutamate Receptor 4 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Metabotropic Glutamate Receptor 4 Sales Market Share by Regions (2015-2020)
Table 13. Global Metabotropic Glutamate Receptor 4 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Metabotropic Glutamate Receptor 4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Metabotropic Glutamate Receptor 4 Sales Share by Manufacturers (2015-2020)
Table 16. Global Metabotropic Glutamate Receptor 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Metabotropic Glutamate Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabotropic Glutamate Receptor 4 as of 2019)
Table 18. Metabotropic Glutamate Receptor 4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Metabotropic Glutamate Receptor 4 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Metabotropic Glutamate Receptor 4 Price (2015-2020) (USD/Pcs)
Table 21. Metabotropic Glutamate Receptor 4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Metabotropic Glutamate Receptor 4 Product Type
Table 23. Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 4 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Metabotropic Glutamate Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Metabotropic Glutamate Receptor 4 Sales Share by Type (2015-2020)
Table 27. Global Metabotropic Glutamate Receptor 4 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Metabotropic Glutamate Receptor 4 Revenue Share by Type (2015-2020)
Table 29. Metabotropic Glutamate Receptor 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Metabotropic Glutamate Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Metabotropic Glutamate Receptor 4 Sales Share by Application (2015-2020)
Table 32. North America Metabotropic Glutamate Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Metabotropic Glutamate Receptor 4 Sales Market Share by Country (2015-2020)
Table 34. North America Metabotropic Glutamate Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Metabotropic Glutamate Receptor 4 Revenue Market Share by Country (2015-2020)
Table 36. North America Metabotropic Glutamate Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Metabotropic Glutamate Receptor 4 Sales Market Share by Type (2015-2020)
Table 38. North America Metabotropic Glutamate Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Metabotropic Glutamate Receptor 4 Sales Market Share by Application (2015-2020)
Table 40. Europe Metabotropic Glutamate Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Metabotropic Glutamate Receptor 4 Sales Market Share by Country (2015-2020)
Table 42. Europe Metabotropic Glutamate Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Metabotropic Glutamate Receptor 4 Revenue Market Share by Country (2015-2020)
Table 44. Europe Metabotropic Glutamate Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Metabotropic Glutamate Receptor 4 Sales Market Share by Type (2015-2020)
Table 46. Europe Metabotropic Glutamate Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Metabotropic Glutamate Receptor 4 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Metabotropic Glutamate Receptor 4 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Metabotropic Glutamate Receptor 4 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Metabotropic Glutamate Receptor 4 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Metabotropic Glutamate Receptor 4 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Metabotropic Glutamate Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Metabotropic Glutamate Receptor 4 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Metabotropic Glutamate Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Metabotropic Glutamate Receptor 4 Sales Market Share by Application (2015-2020)
Table 56. Latin America Metabotropic Glutamate Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Metabotropic Glutamate Receptor 4 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Metabotropic Glutamate Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Metabotropic Glutamate Receptor 4 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Metabotropic Glutamate Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Metabotropic Glutamate Receptor 4 Sales Market Share by Type (2015-2020)
Table 62. Latin America Metabotropic Glutamate Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Metabotropic Glutamate Receptor 4 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Metabotropic Glutamate Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Metabotropic Glutamate Receptor 4 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Metabotropic Glutamate Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Metabotropic Glutamate Receptor 4 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Metabotropic Glutamate Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Metabotropic Glutamate Receptor 4 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Metabotropic Glutamate Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Metabotropic Glutamate Receptor 4 Sales Market Share by Application (2015-2020)
Table 72. Addex Therapeutics Ltd Corporation Information
Table 73. Addex Therapeutics Ltd Description and Major Businesses
Table 74. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Addex Therapeutics Ltd Product
Table 76. Addex Therapeutics Ltd Recent Development
Table 77. Domain Therapeutics SA Corporation Information
Table 78. Domain Therapeutics SA Description and Major Businesses
Table 79. Domain Therapeutics SA Metabotropic Glutamate Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Domain Therapeutics SA Product
Table 81. Domain Therapeutics SA Recent Development
Table 82. Prexton Therapeutics SA Corporation Information
Table 83. Prexton Therapeutics SA Description and Major Businesses
Table 84. Prexton Therapeutics SA Metabotropic Glutamate Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Prexton Therapeutics SA Product
Table 86. Prexton Therapeutics SA Recent Development
Table 87. Global Metabotropic Glutamate Receptor 4 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 88. Global Metabotropic Glutamate Receptor 4 Sales Market Share Forecast by Regions (2021-2026)
Table 89. Global Metabotropic Glutamate Receptor 4 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 90. Global Metabotropic Glutamate Receptor 4 Revenue Market Share Forecast by Regions (2021-2026)
Table 91. North America: Metabotropic Glutamate Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. North America: Metabotropic Glutamate Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Europe: Metabotropic Glutamate Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 94. Europe: Metabotropic Glutamate Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Asia Pacific: Metabotropic Glutamate Receptor 4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 96. Asia Pacific: Metabotropic Glutamate Receptor 4 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 97. Latin America: Metabotropic Glutamate Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. Latin America: Metabotropic Glutamate Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Middle East and Africa: Metabotropic Glutamate Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 100. Middle East and Africa: Metabotropic Glutamate Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 102. Key Challenges
Table 103. Market Risks
Table 104. Main Points Interviewed from Key Metabotropic Glutamate Receptor 4 Players
Table 105. Metabotropic Glutamate Receptor 4 Customers List
Table 106. Metabotropic Glutamate Receptor 4 Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of FiguresFigure 1. Metabotropic Glutamate Receptor 4 Product Picture
Figure 2. Global Metabotropic Glutamate Receptor 4 Sales Market Share by Type in 2020 & 2026
Figure 3. VU-0418506 Product Picture
Figure 4. ADX-88178 Product Picture
Figure 5. JBPOS-0101 Product Picture
Figure 6. PXT-2331 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Metabotropic Glutamate Receptor 4 Sales Market Share by Application in 2020 & 2026
Figure 9. Anxiety Disorders
Figure 10. Autism
Figure 11. Depression
Figure 12. Drug Addiction
Figure 13. Others
Figure 14. Metabotropic Glutamate Receptor 4 Report Years Considered
Figure 15. Global Metabotropic Glutamate Receptor 4 Market Size 2015-2026 (US$ Million)
Figure 16. Global Metabotropic Glutamate Receptor 4 Sales 2015-2026 (K Pcs)
Figure 17. Global Metabotropic Glutamate Receptor 4 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Metabotropic Glutamate Receptor 4 Sales Market Share by Region (2015-2020)
Figure 19. Global Metabotropic Glutamate Receptor 4 Sales Market Share by Region in 2019
Figure 20. Global Metabotropic Glutamate Receptor 4 Revenue Market Share by Region (2015-2020)
Figure 21. Global Metabotropic Glutamate Receptor 4 Revenue Market Share by Region in 2019
Figure 22. Global Metabotropic Glutamate Receptor 4 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Metabotropic Glutamate Receptor 4 Revenue in 2019
Figure 24. Metabotropic Glutamate Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Metabotropic Glutamate Receptor 4 Sales Market Share by Type (2015-2020)
Figure 26. Global Metabotropic Glutamate Receptor 4 Sales Market Share by Type in 2019
Figure 27. Global Metabotropic Glutamate Receptor 4 Revenue Market Share by Type (2015-2020)
Figure 28. Global Metabotropic Glutamate Receptor 4 Revenue Market Share by Type in 2019
Figure 29. Global Metabotropic Glutamate Receptor 4 Market Share by Price Range (2015-2020)
Figure 30. Global Metabotropic Glutamate Receptor 4 Sales Market Share by Application (2015-2020)
Figure 31. Global Metabotropic Glutamate Receptor 4 Sales Market Share by Application in 2019
Figure 32. Global Metabotropic Glutamate Receptor 4 Revenue Market Share by Application (2015-2020)
Figure 33. Global Metabotropic Glutamate Receptor 4 Revenue Market Share by Application in 2019
Figure 34. North America Metabotropic Glutamate Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Metabotropic Glutamate Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Metabotropic Glutamate Receptor 4 Sales Market Share by Country in 2019
Figure 37. North America Metabotropic Glutamate Receptor 4 Revenue Market Share by Country in 2019
Figure 38. U.S. Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Metabotropic Glutamate Receptor 4 Market Share by Type in 2019
Figure 43. North America Metabotropic Glutamate Receptor 4 Market Share by Application in 2019
Figure 44. Europe Metabotropic Glutamate Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Metabotropic Glutamate Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Metabotropic Glutamate Receptor 4 Sales Market Share by Country in 2019
Figure 47. Europe Metabotropic Glutamate Receptor 4 Revenue Market Share by Country in 2019
Figure 48. Germany Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Metabotropic Glutamate Receptor 4 Market Share by Type in 2019
Figure 59. Europe Metabotropic Glutamate Receptor 4 Market Share by Application in 2019
Figure 60. Asia Pacific Metabotropic Glutamate Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Metabotropic Glutamate Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Metabotropic Glutamate Receptor 4 Sales Market Share by Region in 2019
Figure 63. Asia Pacific Metabotropic Glutamate Receptor 4 Revenue Market Share by Region in 2019
Figure 64. China Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Metabotropic Glutamate Receptor 4 Market Share by Type in 2019
Figure 87. Asia Pacific Metabotropic Glutamate Receptor 4 Market Share by Application in 2019
Figure 88. Latin America Metabotropic Glutamate Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Metabotropic Glutamate Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Metabotropic Glutamate Receptor 4 Sales Market Share by Country in 2019
Figure 91. Latin America Metabotropic Glutamate Receptor 4 Revenue Market Share by Country in 2019
Figure 92. Mexico Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Metabotropic Glutamate Receptor 4 Market Share by Type in 2019
Figure 99. Latin America Metabotropic Glutamate Receptor 4 Market Share by Application in 2019
Figure 100. Middle East and Africa Metabotropic Glutamate Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Metabotropic Glutamate Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Metabotropic Glutamate Receptor 4 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Metabotropic Glutamate Receptor 4 Revenue Market Share by Country in 2019
Figure 104. Turkey Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Metabotropic Glutamate Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Metabotropic Glutamate Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Metabotropic Glutamate Receptor 4 Market Share by Type in 2019
Figure 111. Middle East and Africa Metabotropic Glutamate Receptor 4 Market Share by Application in 2019
Figure 112. North America Metabotropic Glutamate Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Metabotropic Glutamate Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Metabotropic Glutamate Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Metabotropic Glutamate Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Metabotropic Glutamate Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Metabotropic Glutamate Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Metabotropic Glutamate Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Metabotropic Glutamate Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Metabotropic Glutamate Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Metabotropic Glutamate Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed